To assess the level of concordance with international consensus on asthma m
anagement, we compared primary care prescribing patterns for asthma in diff
erent European countries.
A prospective study of prescription items with an associated diagnostic lab
el of asthma in patient consultations with a total of 235 general practitio
ners (GPs) from Belgium, England, Ireland, Italy, Northern Ireland, Portuga
l, Scotland and Spain was performed. A total of 101 544 consecutive consult
ations were recorded in autumns 1994 and 1995 of which 3595 (3.5%) were for
patients with asthma and 3243 (3.2%) were for patients receiving a prescri
ption for asthma.
Overall asthma consultations varied from 1.8% in Italy to 5.8% in Ireland (
mean 3.4%, so 1.6). Prescribed inhaled medications for children varied from
72% of the total asthma prescriptions in Ireland and Portugal to 82% in No
rthern Ireland (mean 79%, SD 8.1) and for adults 55% in Italy to 85% in Spa
in (mean 70%, SD 10). Inhaled corticosteroid usage for adults varied from 1
4% in Italy to 31%; in Northern Ireland (mean 24%, SD 6.4). Far children, b
eta(2)-agonist use varied from 24% in Italy to 67% in Spain (mean 45%, SD 1
3).
Despite publication of international guidelines for the management of asthm
a, inter-country prescribing practices vary considerably and could be impro
ved. The frequency of use of asthma as a diagnostic label also varies marke
dly.